Last 24.00 NOK
Change Today 0.00 / 0.00%
Volume 1.2K
PHO On Other Exchanges
Symbol
Exchange
OTC US
Oslo
Stuttgart
As of 10:25 AM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

photocure asa (PHO) Snapshot

Open
24.50 NOK
Previous Close
24.00 NOK
Day High
24.50 NOK
Day Low
24.00 NOK
52 Week High
08/6/13 - 41.60 NOK
52 Week Low
12/27/13 - 21.10 NOK
Market Cap
513.4M
Average Volume 10 Days
2.8K
EPS TTM
-2.76 NOK
Shares Outstanding
21.4M
EX-Date
05/23/13
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHOTOCURE ASA (PHO)

Related News

No related news articles were found.

photocure asa (PHO) Related Businessweek News

No Related Businessweek News Found

photocure asa (PHO) Details

Photocure ASA engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products and related technical medical equipment. The company offers Hexvix/Cysview for the detection of bladder cancer. Its products pipeline includes Visonac that has completed phase IIb study for the treatment of moderate to severe acne; Cevira, which is under phase IIb study for the treatment of human papilloma virus disease and precancerous lesions of the cervix; and Lumacan that is under phase I/II development for the detection of colorectal cancer. The company sells its products to license partners, pharmaceutical wholesalers, and hospitals. It has strategic agreement with Salix Pharmaceuticals Inc. for the development and commercialization of Lumacan. The company operates in Norway, Sweden, Denmark, Finland, and the United States. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.

Founded in 1997

photocure asa (PHO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

photocure asa (PHO) Key Developments

Photocure Group Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2013

Photocure Group reported earnings results for the fourth quarter and year ended December 31, 2013. For the quarter, the company reported total revenues of NOK 26.3 million against NOK 47.3 million a year ago. Operating loss recurring was NOK 19.362 million against operating profit recurring of NOK 2.480 million a year ago. Operating loss incl. non-recurring was NOK 19.067 million against operating profit incl. non-recurring of NOK 2.480 million a year ago. Loss before tax was NOK 17.317 million against profit before tax of NOK 4.836 million a year ago. Net loss from continued operations was NOK 9.113 million against net profit from continued operations of NOK 5.726 million a year ago. Net loss was NOK 9.156 million or NOK 0.43 per diluted share against net profit of NOK 3.305 million or NOK 0.07 per diluted share a year ago. Net cash used in operations was NOK 17.771 million against net cash flow from operations of NOK 27.507 million a year ago. For the year, the company reported total Revenue was NOK 83.6 million against NOK 133.8 million a year ago. Operating loss recurring was NOK 71.846 million against NOK 39.248 million a year ago. Operating loss incl. non-recurring was NOK 75.540 million against NOK 39.248 million a year ago. Loss before tax was NOK 66.852 million against NOK 31.012 million a year ago. Net loss from continued operations was NOK 58.648 million against NOK 30.122 million a year ago. Net loss was NOK 58.950 million or NOK 2.77 per diluted share against NOK 47.900 million or NOK 2.24 per diluted share a year ago. Net cash flow from operations was NOK 99.722 million against NOK 54.928 million a year ago.

PhotoCure ASA, Q4 2013 Earnings Call, Feb 27, 2014

PhotoCure ASA, Q4 2013 Earnings Call, Feb 27, 2014

PhotoCure ASA to Report Q4, 2013 Results on Feb 27, 2014

PhotoCure ASA announced that they will report Q4, 2013 results on Feb 27, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHO:NO 24.00 NOK 0.00

PHO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHO.
View Industry Companies
 

Industry Analysis

PHO

Industry Average

Valuation PHO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.2x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHOTOCURE ASA, please visit www.photocure.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.